Assorted News from the Last Week: Survival rates for cancer patients on immunotherapy depend on insurance coverage: Those on private insurance or Medicaid had higher survival
Assorted News from the Last Week: CAC2 Guest Blog Post–The National Cancer Institute (NCI) will host the CCDI Symposium this October and bring together the
The National Cancer Institute (NCI) will host the CCDI Symposium this October and bring together the childhood cancer community to learn about CCDI programs and
Assorted News from the Last Week: Nutritional status, body composition, and chemotherapy dosing in children and young people with cancer: a systematic review by the
Assorted News from the Last Week: CAC2 sends childhood cancer survivors a Thank You note. Targeting fusion protein’s role in childhood leukemia produces striking results.
Dear Childhood Cancer Survivors, As Childhood Cancer Survivorship Month is drawing to a close, the Coalition Against Childhood Cancer (CAC2) extends our gratitude to each
Assorted News from the Last Week: My 5-year-old survived cancer twice. Medical innovation shouldn’t be political. Pediatric patients with diffuse midline gliomas (DMGs) may have
Assorted News from the Last Week: The Global Initiative for Childhood Cancer aims for a two-thirds remission rate by 2030, saving the lives of approximately
In CAC2’s June webinar, “Beyond the Signature: Demystifying Informed Consent in Childhood Cancer,” we brought together an extraordinary panel of experts, including a clinical ethicist,
Assorted News from the Last Week: Children and young people are waiting longer than necessary for cancer diagnosis, according to new research. Disruptions to school,
